Cmv-hiv specific chimeric antigen receptor t cells
AssigneeCity of Hope
InventorsXiuli Wang, John Zaia, Lihua Elizabeth Budde, Stephen J. Forman, Don J. Diamond
Life of this patent
Estimating the term…
Abstract
This disclosure relates, inter alia, to compositions comprising and methods making and using T cells expressing both a chimeric antigen receptor (CAR) targeted to HIV and a T cell receptor targeted to cytomegalovirus (CMV).
Claims42
A nucleic acid molecule encoding a chimeric antigen receptor, wherein the chimeric antigen receptor comprises:
- (i) an scFv that binds HIV Env;
- (ii) a spacer domain;
- (iii) a transmembrane domain;
- (iv) a costimulatory domain;
- and
- (v) a CD3ζ signaling domain.
A nucleic acid molecule encoding a chimeric antigen receptor, wherein the chimeric antigen receptor comprises:
- a scFv comprising or consisting of RAHLVQSGTAMKKPGASVRVSCQTSGYTFTAHILFWFRQAPGRGLEWVGWIKPQYGAVN FGGGFRDRVTLTRDVYREIAYMDIRGLKPDDTAVYYCARDRSYGDSSWALDAWGQGTTVV VSAGGGSGGGSGGGSGGGSYIHVTQSPSSLSVSIGDRVTINCQTSQGVGSDLHWYQHKP GRAPKLLIHHTSSVEDGVPSRFSGSGFHTSFNLTISDLQADDIATYYCQVLQFFGRGSRLHI K;
- a spacer comprising a sequence selected from the group consisting of:
- SEQ ID NOs:
- 24-34;
- a transmembrane domain comprising a sequence selected from the group consisting of SEQ ID NOs:
- 15-23;
- a costimulatory domain comprising a sequence selected from the group consisting of SEQ ID NOs:
- 36-40, and a CD3ζ signaling domain comprising SEQ ID NO:
- 35.
An immune cell harboring the nucleic acid molecule of any of the forgoing claims.
A method for treating a subject infected with HIV, the method comprising administering:
- (a) a population of CMV-specific T cells expressing chimeric antigen receptor comprising:
- an scFv that binds HIV Env;
- a spacer domain;
- a transmembrane domain;
- a costimulatory domain;
- and a CD3ζ signaling domain;
- and, optionally, (b) at least one CMV antigen or a nucleic acid molecule encoding at least one CMV antigen.
Dependencies are inferred from the claim text.